Candel Therapeutics (CADL) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free CADL Stock Alerts $10.83 +1.24 (+12.93%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Candel Therapeutics Short Interest DataCurrent Short Volume2,030,000 sharesPrevious Short Volume160,900 sharesChange Vs. Previous Month+1,161.65%Dollar Volume Sold Short$11.81 millionShort Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Outstanding Shares29,350,000 sharesFloat Size15,660,000 sharesShort Percent of Float12.96%Today's Trading Volume1,146,447 sharesAverage Trading Volume3,859,184 sharesToday's Volume Vs. Average30% Short Selling Candel Therapeutics ? Sign up to receive the latest short interest report for Candel Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCADL Short Interest Over TimeCADL Days to Cover Over TimeCADL Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Candel Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,030,000 shares $11.81 million +1,161.7%13.0%0.4 $5.82 3/31/2024160,900 shares $254,222.00 +9.2%1.0%0 $1.58 3/15/2024147,300 shares $220,950.00 -24.7%1.0%1.7 $1.50 2/29/2024195,600 shares $363,816.00 -30.4%1.3%0.3 $1.86 2/15/2024281,200 shares $489,288.00 +69.2%1.8%0.5 $1.74 1/31/2024166,200 shares $216,060.00 -10.9%1.1%0.3 $1.30 Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024186,600 shares $248,178.00 -9.2%1.2%0.3 $1.33 12/31/2023205,400 shares $301,938.00 -54.9%1.3%0.4 $1.47 12/15/2023455,500 shares $610,370.00 +1,071.0%2.9%0.8 $1.34 11/30/202338,900 shares $34,971.10 -5.8%0.3%1.3 $0.90 11/15/202341,300 shares $40,350.10 -40.8%0.3%1.3 $0.98 10/31/202369,800 shares $62,813.02 -56.4%0.4%2.3 $0.90 10/15/2023159,900 shares $143,910.00 -0.8%1.0%7.2 $0.90 9/30/2023161,200 shares $148,304.00 +0.5%1.0%8.8 $0.92 9/15/2023160,400 shares $202,104.00 -2.1%1.0%8.2 $1.26 8/31/2023163,900 shares $199,958.00 +1.2%1.0%9 $1.22 8/15/2023162,000 shares $187,920.00 -5.9%1.0%8.3 $1.16 7/31/2023172,100 shares $185,868.00 +8.6%1.0%8.8 $1.08 7/15/2023158,500 shares $183,860.00 -4.4%1.0%7.2 $1.16 6/30/2023165,800 shares $208,908.00 +20.9%1.0%4.9 $1.26 6/15/2023137,200 shares $196,196.00 +9.8%0.8%4.3 $1.43 5/31/2023125,000 shares $188,750.00 -7.3%0.8%3.9 $1.51 5/15/2023134,800 shares $215,680.00 +0.2%0.8%4.4 $1.60 4/30/2023134,500 shares $173,505.00 +163.2%0.8%4.5 $1.29 4/15/202351,100 shares $72,562.00 No Change0.3%1.6 $1.42 3/31/202351,100 shares $68,985.00 +24.3%0.3%2.4 $1.35 3/15/202341,100 shares $61,650.00 +43.7%0.3%1.5 $1.50 2/28/202328,600 shares $51,480.00 +2.1%0.2%0.8 $1.80 2/15/202328,000 shares $56,000.00 +20.7%0.2%0.8 $2.00 1/31/202323,200 shares $59,612.40 -16.6%0.2%0.6 $2.57 1/15/202327,800 shares $57,824.00 -9.5%0.2%0.5 $2.08 12/30/202230,700 shares $54,953.00 -39.8%0.3%0.6 $1.79 12/15/202251,000 shares $96,390.00 +38.6%0.6%1.2 $1.89 11/30/202236,800 shares $64,400.00 -16.0%0.4%1 $1.75 11/15/202243,800 shares $79,278.00 -6.8%0.5%1.2 $1.81 10/31/202247,000 shares $91,180.00 -2.7%0.5%1.2 $1.94 10/15/202248,300 shares $122,682.00 -16.2%0.5%1.5 $2.54 9/30/202257,600 shares $180,864.00 +12.3%0.6%3.1 $3.14 9/15/202251,300 shares $175,959.00 +4.3%0.5%3.1 $3.43 8/31/202249,200 shares $170,724.00 -5.0%0.5%3.2 $3.47Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here CADL Short Interest - Frequently Asked Questions What is Candel Therapeutics' current short interest? Short interest is the volume of Candel Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 2,030,000 shares of CADL short. 12.96% of Candel Therapeutics' shares are currently sold short. Learn More on Candel Therapeutics' current short interest. What is a good short interest percentage for Candel Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.96% of Candel Therapeutics' floating shares are currently sold short. Is Candel Therapeutics' short interest increasing or decreasing? Candel Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,030,000 shares, an increase of 1,161.7% from the previous total of 160,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Candel Therapeutics' float size? Candel Therapeutics currently has issued a total of 29,350,000 shares. Some of Candel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Candel Therapeutics currently has a public float of 15,660,000 shares. How does Candel Therapeutics' short interest compare to its competitors? 12.96% of Candel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Candel Therapeutics: Poseida Therapeutics, Inc. (6.55%), Monte Rosa Therapeutics, Inc. (5.91%), Adaptimmune Therapeutics plc (1.38%), Sutro Biopharma, Inc. (3.49%), Invivyd, Inc. (7.05%), Fennec Pharmaceuticals Inc (8.08%), Coherus BioSciences, Inc. (18.97%), Anavex Life Sciences Corp. (26.81%), UroGen Pharma Ltd. (17.91%), Agenus Inc. (13.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Candel Therapeutics stock? Short selling CADL is an investing strategy that aims to generate trading profit from Candel Therapeutics as its price is falling. CADL shares are trading up $1.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Candel Therapeutics? A short squeeze for Candel Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CADL, which in turn drives the price of the stock up even further. How often is Candel Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CADL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PSTX Short Interest GLUE Short Interest ADAP Short Interest STRO Short Interest IVVD Short Interest FENC Short Interest CHRS Short Interest AVXL Short Interest URGN Short Interest AGEN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CADL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders